Ah Equity Partners Bio Ii, L.L.C. has filed its 13F form on November 14, 2022 for Q3 2022 where it was disclosed a total value porftolio of $144 Million distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eq Rx, Inc. with a value of $86.3M, Nautilus Biotechnology, Inc. with a value of $34.6M, Erasca, Inc. with a value of $19.5M, and Invitae Corp with a value of $3.14M.

Examining the 13F form we can see an increase of $1.1M in the current position value, from $142M to 144M.

Ah Equity Partners Bio Ii, L.L.C. is based out at Menlo Park, CA

Below you can find more details about Ah Equity Partners Bio Ii, L.L.C. portfolio as well as his latest detailed transactions.

Portfolio value $144 Million
Healthcare: $144 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 4
  • Current Value $144 Million
  • Prior Value $142 Million
  • Filing
  • Period Q3 2022
  • Filing Date November 14, 2022
  • Form Type 13F-HR
  • Activity in Q3 2022
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Ah Equity Partners Bio Ii, L.L.C. Portfolio

Follow Ah Equity Partners Bio Ii, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ah Equity Partners Bio Ii, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Ah Equity Partners Bio Ii, L.L.C. with notifications on news.